there is yet another article in the new york times on zyprexa today it is not flattering to make a long and sad story short , a patient gained a lot of weight on zyprexa pounds over five years and died of a heart attack granted , who knows if the zyprexa was responsible for the weight gain and subsequent death , but it raises suspicions the part of the article i ll focus on is the language used by lilly in its response as i ve alluded to in a prior post , lilly has trotted out newspeak , or maximum pr , to defend its drug one of their statements regarding the latest incident was zyprexa is a lifesaving drug does zyprexa save lives ? as a class of drugs , atypical antipsychotics , of which zyprexa is a member relate to a higher death rate compared to placebo for elderly patients with dementia in schizophrenia , compared to clozapine , zyprexa is associated with more suicide attempts i am not familiar with any research showing that zyprexa relates to fewer suicide attempts than any other treatment or less suicide than a placebo please inform me of any studies to the contrary i could have missed something enough about suicide we know that zyprexa can cause diabetes and we know that diabetes is not good for one s health and life expectancy now , the clincher from the new york times story today lilly s own clinical trials show the drug causes percent of the patients who take zyprexa to gain more than pounds after a year yeah , that s a lifesaver hat tip furious seasons